RT Journal Article
SR Electronic
T1 SARS-CoV-2 specific T cells and antibodies in COVID-19 protection: a prospective study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.08.19.21262278
DO 10.1101/2021.08.19.21262278
A1 Molodtsov, Ivan A.
A1 Kegeles, Evgenii
A1 Mitin, Alexander N.
A1 Mityaeva, Olga
A1 Musatova, Oksana E.
A1 Panova, Anna E.
A1 Pashenkov, Mikhail V.
A1 Peshkova, Iuliia O.
A1 Almaqdad, Alsalloum
A1 Asaad, Walaa
A1 Budikhina, Anna S.
A1 Deryabin, Aleksander S.
A1 Dolzhikova, Inna V.
A1 Filimonova, Ioanna N.
A1 Gracheva, Alexandra N.
A1 Ivanova, Oxana I.
A1 Kizilova, Anastasia
A1 Komogorova, Viktoria V.
A1 Komova, Anastasia
A1 Kompantseva, Natalia I.
A1 Lagutkin, Denis A.
A1 Lomakin, Yakov A.
A1 Maleeva, Alexandra V.
A1 Maryukhnich, Elena V.
A1 Mohammad, Afraa
A1 Murugin, Vladimir V.
A1 Murugina, Nina E.
A1 Navoikova, Anna
A1 Nikonova, Margarita F.
A1 Ovchinnikova, Leyla A.
A1 Pinegina, Natalia V.
A1 Potashnikova, Daria M.
A1 Romanova, Elizaveta V.
A1 Saidova, Aleena A.
A1 Sakr, Nawar
A1 Samoilova, Anastasia G.
A1 Serdyuk, Yana
A1 Shakirova, Naina T.
A1 Sharova, Nina I.
A1 Sheetikov, Savely A.
A1 Shemetova, Anastasia F.
A1 Shevkova, Liudmila
A1 Shpektor, Alexander V.
A1 Trufanova, Anna
A1 Tvorogova, Anna V.
A1 Ukrainskaya, Valeria M.
A1 Vinokurov, Anatoliy S.
A1 Vorobyeva, Daria A.
A1 Zornikova, Ksenia V.
A1 Efimov, Grigory A.
A1 Khaitov, Musa R.
A1 Kofiadi, Ilya A.
A1 Komissarov, Alexey A.
A1 Logunov, Denis Y.
A1 Naigovzina, Nelli B.
A1 Rubtsov, Yury P.
A1 Vasilyeva, Irina A.
A1 Volchkov, Pavel
A1 Vasilieva, Elena
YR 2021
UL http://medrxiv.org/content/early/2021/10/06/2021.08.19.21262278.abstract
AB Rapid spread of COVID-19 pandemic made a substantial share of the world population immunised by SARS-CoV-2 antigens. Infection induces the development of virus-specific antibodies and T cells. Ample evidence on the antibody-mediated protection is contrasted by the elusive role of T cells in preventing infection. To explore the impact of T cells and to quantify the protective levels of the immune responses we conducted a large prospective study: 5,340 Moscow residents were evaluated for the antibody and cellular immune responses to SARS-CoV-2 and monitored for COVID-19 up to 300 days. The antibody and cellular responses were tightly interconnected, their magnitude inversely correlated with infection probability. Similar maximal level of protection was reached by individuals positive for both types of responses and by individuals with antibodies alone. Meanwhile, T cells in the absence of antibodies provided an intermediate level of protection. The real-world data on the protective effects of T cells have important implications for T cell immunology and development of the strategies to fight the pandemic.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04898140Funding StatementThe authors thank the Moscow Department of Healthcare for the help in organization of the study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Moscow City Ethics Committee of the Research Institute of the Organization of Health and Healthcare Management and performed according to the Helsinki Declaration. All participants provided their written informed consent. The study was registered on ClinicalTrials.gov (Identifier: NCT04898140).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData available within the article and supplementary materials